{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.89 vs. cons $1.85",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Health Care Benefits adjusted operating income",
      "prediction": "BEAT",
      "answer": "pred ~$1.60B vs. cons $1.54B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Health Services adjusted operating income",
      "prediction": "MISS",
      "answer": "pred ~$1.40B vs. cons $1.46B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 adjusted EPS guidance",
      "prediction": "LOWER",
      "answer": "guide ~$7.40 midpoint vs. cons $7.47 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 operating cash flow guidance",
      "prediction": "LOWER",
      "answer": "guide ~$9.50B vs. cons $9.75B (FY2026)",
      "confidence": "LOW"
    },
    {
      "kpi": "FY2026 revenue guidance",
      "prediction": "LOWER",
      "answer": "guide ~$405.0B vs. cons $406.2B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 Health Care Benefits MBR commentary",
      "prediction": "UNCHANGED",
      "answer": "guide ~90.5% vs. cons 90.4% (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -1.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -3.6,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A ~$1.89 EPS result versus $1.85 consensus and stronger ~$1.60B Health Care Benefits profit versus $1.54B are outweighed by a likely unchanged ~$7.40 FY2026 EPS midpoint versus $7.47 consensus and ~$9.50B operating-cash-flow guide versus $9.75B consensus. The implied second-half EPS burden remains demanding, while the ~$1.40B Health Services result versus $1.46B consensus reinforces out-period estimate risk.",
  "day5_confidence": "MEDIUM"
}